Explaining fatigue in ANCA-associated vasculitis

Rheumatology (United Kingdom)

Volumn 52, Issue 9, 2013, Pages 1680-1685

  Basu, Neil ^a   Mcclean, Andrew ^b   Harper, Lorraine ^b   Amft, Esther N ^c   Dhaun, Neeraj ^d   Luqmani, Raashid A ^e   Little, Mark A ^f   Jayne, David R W ^g   Flossmann, Oliver ^h   Mclaren, John ⁱ   Kumar, Vinod ⁱ   Erwig, Lars P ^a   Reid, David M ^a   Macfarlane, Gary J ^a   Jones, Gareth T ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

^d ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f TRINITY COLLEGE DUBLIN   (Ireland)

^g ADDENBROOKE S HOSPITAL   (United Kingdom)

^h ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

ⁱ NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

ANCA associated vasculitis; Eosinophilic granulomatosis with polyangiitis; Fatigue; Granulomatosis with polyangiitis; Microscopic polyangiitis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANCA ASSOCIATED VASCULITIS; ARTICLE; COPING BEHAVIOR; CROSS-SECTIONAL STUDY; DENIAL; EOSINOPHILIC GRANULOMA; FATIGUE; FEMALE; GENDER; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; MULTICENTER STUDY; PAIN; PRIORITY JOURNAL; QUESTIONNAIRE; SLEEP DISORDER;

ANCA-ASSOCIATED VASCULITIS; EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS; FATIGUE; GRANULOMATOSIS WITH POLYANGIITIS; MICROSCOPIC POLYANGIITIS;

ADAPTATION, PSYCHOLOGICAL; AGED; CHURG-STRAUSS SYNDROME; CROSS-SECTIONAL STUDIES; FATIGUE; FEMALE; HUMANS; MALE; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; PAIN; QUESTIONNAIRES; SEX FACTORS; SLEEP DISORDERS; WEGENER GRANULOMATOSIS;

EID: 84882994108     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket191     Document Type: Article

References (36)

1. Walton EW. Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis). Br Med J 19582:265-70.
2. Flossmann O, Berden A, De Groot K et al. Long-term survival of ANCA-associated vasculitis. APMIS 2009117: 139.
3. Herlyn K, Hellmich B, Seo P et al. Patient-reported outcome assessment in vasculitis provides important data and a unique perspective. Arthritis Care Res 201062: 1639-45.
4. Basu N MA, Harper L, Amft EN et al. Determinants of poor quality of life in ANCA associated vasculitis. Ann Rheum Dis 2013. Advance Access published 25 January 2013, doi:10.1136/annrheumdis-2012-202750.
5. Basu N, Jones GT, Fluck N et al. Fatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitis. Rheumatology 201049:1383-90.
6. Hajj-Ali RA, Wilke WS, Calabrese LH et al. Pilot study to assess the frequency of fibromyalgia, depression, and sleep disorders in patients with granulomatosis with polyangiitis (Wegener's). Arthritis Care Res 201163: 827-33.
7. Faurschou M, Sigaard L, Bjorner JB et al. Impaired healthrelated quality of life in patients treated for Wegener's granulomatosis. J Rheumatol 201037:2081-5.
8. Koutantji M, Harrold E, Lane SE et al. Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis. Arthritis Rheum 200349: 826-37.
9. Chalder T, Berelowitz G, Pawlikowska T et al. Development of a fatigue scale. J Psychosom Res 199337: 147-53.
10. Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res 200456:157-70.
11. Hjollund NH, Andersen JH, Bech P. Assessment of fatigue in chronic disease: a bibliographic study of fatigue measurement scales. Health Qual Life Outcomes 20075:12.
12. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 198367:361-70.
13. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale-a review of validation data and clinical results. J Psychosom Res 199742:17-41.
14. Bjelland I, Dahl AA, Haug TT et al. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 200252:69-77.
15. Jenkins CD, Stanton BA, Niemcryk SJ et al. A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol 198841:313-21.
16. Deodhar A, Braun J, Inman RD et al. Golimumab reduces sleep disturbance in patients with active ankylosing spondylitis: results from a randomized, placebo-controlled trial. Arthritis Care Res 201062:1266-71.
17. Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med 19974:92-100.
18. Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes 20031:29.
19. Mukhtyar C, Lee R, Brown D et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 200968:1827-32.
20. Exley A, Banbury P, Carruthers D et al. The Vasculitis Damage Index (VDI). Arthritis Rheum 199538:1124.
21. Charlson M, Szatrowski TP, Peterson J et al. Validation of a combined comorbidity index. J Clin Epidemiol 199447: 1245-51.
22. WHO. Global database on body mass index. 2012. http://apps.who.int/bmi/index.jsp?introPage=intro_3.html (4 February 2012, date last accessed).
23. Kirkwood BR, Sterne JAC, Kirkwood BR. Essential medical statistics, 2nd edn. Oxford: Blackwell Science, 2003.
24. Frankel SK, Sullivan EJ, Brown KK. Vasculitis: Wegener granulomatosis, Churg-Strauss syndrome, microscopic AAV-related fatigue polyangiitis, polyarteritis nodosa, and Takayasu arteritis. Crit Care Clin 200218:855-79.
25. Eberhard OK, Haubitz M, Brunkhorst FM et al. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibodyassociated vasculitis) and invasive bacterial infection. Arthritis Rheum 199740:1250-6.
26. Jayne DR, Gaskin G, Pusey CD et al. ANCA and predicting relapse in systemic vasculitis. QJM 199588: 127-33.
27. van Staa TP, Leufkens HG, Abenhaim L et al. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology 200039:1383-9.
28. Nikolaus S, Bode C, Taal E et al. Fatigue and factors related to fatigue in rheumatoid arthritis: a systematic review. Arthritis Care Res 2013.
29. Swain MG. Fatigue in chronic disease. Clin Sci 200099: 1-8.
30. NICE. Guidance on the use of zaleplon, zolpidem and zopiclone for the short term management of insominia. 2004. www.nice.otg/TA077guidance (11 March 2012, date last accessed).
31. Kwekkeboom KL, Cherwin CH, Lee JW et al. Mind-body treatments for the pain-fatigue-sleep disturbance symptom cluster in persons with cancer. J Pain Symptom Manage 201039:126-38.
32. Neill J, Belan I, Ried K. Effectiveness of non-pharmacological interventions for fatigue in adults with multiple sclerosis, rheumatoid arthritis, or systemic lupus erythematosus: a systematic review. J Adv Nurs 200656: 617-35.
33. Meeus M, Nijs J, Meirleir KD. Chronic musculoskeletal pain in patients with the chronic fatigue syndrome: a systematic review. Eur J Pain 200711:377-86.
34. Gupta A, Silman AJ, Ray D et al. The role of psychosocial factors in predicting the onset of chronic widespread pain: results from a prospective population-based study. Rheumatology 200746:666-71.
35. Lapraik C, Watts R, Bacon P et al. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology 200746:1615-6.
36. Mukhtyar C, Guillevin L, Cid MC et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 200968: 310-7.